References
- Delavari A, Bishehsari F, Salimzadeh H, Khosravi P, Delavari F, Nasseri-Moghaddam S, et al. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence. BMC Gastroenterol. 2014; 14:196. [DOI:10.1186/s12876-014-0196-8] [PMID]
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. [DOI:10.3322/caac.21492] [PMID]
- Ewing I, Hurley JJ, Josephides E, Millar A. The molecular genetics of colorectal cancer. Frontline Gastroenterol. 2014; 5(1):26-30. [DOI:10.1136/flgastro-2013-100329] [PMID]
- Javed Z, Khan K, Sadia H, Raza S, Salehi B, Sharifi-Rad J, et al. LncRNA & Wnt signaling in colorectal cancer. Cancer Cell Int. 2020; 20:326. [DOI:10.1186/s12935-020-01412-7] [PMID]
- Yang T, Zhou H, Liu P, Yan L, Yao W, Chen K, et al. lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression. Oncotarget. 2017; 8(49):85353-67. [DOI:10.18632/oncotarget.19743] [PMID]
- Ren Y, Huang W, Weng G, Cui P, Liang H, Li Y. LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p. Onco Targets Ther. 2019; 12:2563-75. [DOI:10.2147/OTT.S190239] [PMID]
- Li R, Wang X, Zhu C, Wang K. lncRNA PVT1: A novel oncogene in multiple cancers. Cell Mol Biol Lett. 2022; 27(1):84. [DOI:10.1186/s11658-022-00385-x] [PMID]
- Mangan PR, Harrington LE, O’Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature. 2006; 441(7090):231-4. [DOI:10.1038/nature04754] [PMID]
- Iglesias M, Frontelo P, Gamallo C, Quintanilla M. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene. 2000; 19(36):4134-45. [DOI:10.1038/sj.onc.1203764] [PMID]
- Ding J, Li J, Wang H, Tian Y, Xie M, He X, et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death Dis. 2017; 8(8):e2997. [DOI:10.1038/cddis.2017.328] [PMID]
- Li DX, Fei XR, Dong YF, Cheng CD, Yang Y, Deng XF, et al. The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2. Oncotarget. 2017; 8(50):88163-78. [DOI:10.18632/oncotarget.21513] [PMID]
- Berghoff EG, Clark MF, Chen S, Cajigas I, Leib DE, Kohtz JD. Evf2 (Dlx6as) lncRNA regulates ultraconserved enhancer methylation and the differential transcriptional control of adjacent genes. Development. 2013; 140(21):4407-16. [DOI:10.1242/dev.099390] [PMID]
- Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014; 31(11):253. [DOI:10.1007/s12032-014-0253-8] [PMID]
- Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer. 2014; 110(1):164-71. [DOI:10.1038/bjc.2013.698] [PMID]
- Zhang X, Feng W, Zhang J, Ge L, Zhang Y, Jiang X, et al. Long non coding RNA PVT1 promotes epithelial mesenchymal transition via the TGF β/Smad pathway in pancreatic cancer cells. Oncol Rep. 2018; 40(2):1093-102. [DOI:10.3892/or.2018.6462] [PMID]
- Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019; 18(1):33. [PMID]
- Chang Z, Cui J, Song Y. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer. Gene. 2018; 654:36-42. [DOI:10.1016/j.gene.2018.02.036] [PMID]
- Zhao L, Kong H, Sun H, Chen Z, Chen B, Zhou M. LncRNA‐PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR‐ J Cell Physiol. 2018; 233(5):4044-55. [DOI:10.1002/jcp.26072] [PMID]
- Becerril-Rico J, Alvarado-Ortiz E, Toledo-Guzmán ME, Pelayo R, Ortiz-Sánchez E. The cross talk between gastric cancer stem cells and the immune microenvironment: A tumor-promoting factor. Stem Cell Res Ther. 2021; 12(1):498.[DOI:10.1186/s13287-021-02562-9] [PMID]
- Xie F, Ling L, Van Dam H, Zhou F, Zhang L. TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2018; 50(1):121-32. [DOI:10.1093/abbs/gmx123] [PMID]
- Fan H, Zhu JH, Yao XQ. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer. Int J Biol Markers. 2018; 33(4):415-22. [DOI:10.1177/1724600818777242] [PMID]
- David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, et al. TGF-β tumor suppression through a lethal EMT. Cell. 2016; 164(5):1015-30. [DOI:10.1016/j.cell.2016.01.009] [PMID]
- Rodrigues-Junior DM, Moustakas A. Unboxing the network among long non-coding RNAs and TGF-β signaling in cancer. Ups J Med Sci. 2024; 129. [DOI:10.48101/ujms.v129.10614] [PMID]
|